Variables | RILI group (n = 45) | Non-RILI group (n = 81) | χ2/t | P |
---|---|---|---|---|
Male/female | 31/14 | 48/33 | 1.029 | 0.112 |
Age (years) | 61.01 ± 8.52 | 60.17 ± 9.33 | 4.381 | 0.065 |
BMI (kg/m2) | 22.27 ± 4.15 | 22.09 ± 3.98 | 3.424 | 0.082 |
Diabetes | 24 (53.33%) | 20 (24.69%) | 1.187 | 0.013 |
Hypertension | 25 (55.56%) | 44 (54.32%) | 1.272 | 0.104 |
Hyperlipidemia | 10 (22.22%) | 16 (19.75%) | 1.489 | 0.076 |
Smoke | 31 (68.89%) | 24 (29.63%) | 1.233 | 0.014 |
COPD | 18 (40%) | 22 (27.16%) | 1.504 | 0.046 |
Pathological type | ||||
 Squamous cell carcinoma | 32 (71.11%) | 58 (71.61%) | 1.127 | 0.088 |
 Adenocarcinoma | 13 (28.89%) | 23 (28.39%) | ||
Concurrent chemotherapy | 39 (86.67%) | 61 (75.31%) | 1.231 | 0.039 |
KPS | 84.43 ± 12.72 | 82.76 ± 11.23 | 1.107 | 0.092 |
Tumor staging | ||||
 IIIa | 24 (53.33%) | 44 (54.32%) | 1.145 | 0.106 |
 IIIb | 22 (48.89%) | 37 (45.68%) | ||
Cancer size (cm) | 5.88 ± 3.26 | 5.65 ± 2.64 | 1.230 | 0.085 |
Radiotherapy dose (Gy) | 63.75 ± 11.32 | 52.48 ± 10.66 | 9.277 | 0.001 |
V5 | 54.44 ± 11.68 | 53.26 ± 12.42 | 11.207 | 0.073 |
V10 | 32.76 ± 8.01 | 29.19 ± 9.54 | 8.021 | 0.081 |
V20 | 22.12 ± 5.37 | 21.35 ± 5.95 | 9.101 | 0.089 |
V30 | 12.31 ± 4.98 | 11.93 ± 4.17 | 4.116 | 0.105 |
MLD | 949.59 ± 242.83 | 898.91 ± 282.44 | 77.174 | 0.059 |
GTV | 169.05 ± 52.18 | 149.77 ± 61.72 | 18.101 | 0.091 |
PTV | 472.34 ± 69.64 | 321.58 ± 79.84 | 53.374 | 0.011 |